X0306 4 2021-02-10 0 0001743881 BridgeBio Pharma, Inc. BBIO 0001742485 Kumar Neil C/O BRIDGEBIO PHARMA, INC. 421 KIPLING STREET PALO ALTO CA 94301 1 1 0 0 CEO and President Stock Option (Right to Buy) 68.87 2021-02-10 4 A 0 225971 0.00 A 2031-02-09 Common Stock 225971 225971 D Restricted Stock Units 2021-02-10 4 A 0 38306 0.00 A Common Stock 38306 38306 D The option will vest in 48 equal month installments after February 10, 2021, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The units will vest in 16 equal quarterly installments after February 16, 2021, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. /s/ Tara Condon, Attorney-in-Fact 2021-02-12